Search Results

Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells.

• Authors : Rahman, Mohammad Mijanur¹ (AUTHOR); Tollefsbol, Trygve O.^1,2,3,4,5 (AUTHOR)

• Source: Cancer Cell International. 12/20/2024, Vol. 24 Issue 1, p1-20. 20p.

Record details

Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells.

• Authors : Cai, Wanhua^1,2 (AUTHOR); Rong, Dade^2,3 (AUTHOR); Ding, Jiayu² (AUTHOR)

• Source: Cancer Cell International. 7/17/2024, Vol. 24 Issue 1, p1-13. 13p.

Record details

Toxoplasma gondii suppresses proliferation and migration of breast cancer cells by regulating their transcriptome.

• Authors : Ye, Hengming^1,2 (AUTHOR); Zhou, Xiaotao² (AUTHOR); Zhu, Bike² (AUTHOR)

• Source: Cancer Cell International. 4/23/2024, Vol. 24 Issue 1, p1-17. 17p.

Record details

The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitntriors.

• Authors : Muller, Claire¹ (AUTHOR); Lacroix-Malgras, Victorine¹ (AUTHOR); Kluza, Jérôme² (AUTHOR)

• Source: Cancer Cell International. 4/10/2024, Vol. 24 Issue 1, p1-15. 15p.

Record details

PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis.

• Authors : Wang, Yang¹ (AUTHOR); Wang, Jieyi² (AUTHOR); Chen, Lan¹ (AUTHOR)

• Source: Cancer Cell International. 12/16/2023, Vol. 23 Issue 1, p1-17. 17p.

Record details

PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis

• Authors : Marwa Elfoly; Jumanah Y. Mirza; Ayodele Alaiya

Subjects: PD-L1; Proliferation; SKP2

• Source: Cancer Cell International, Vol 24, Iss 1, Pp 1-16 (2024)

Record details

Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways

• Authors : Hadeel Kheraldine; Ishita Gupta; Farhan Sachal Cyprian

Subjects: Dasatinib; PD-1/PD-L1; HER2-positive breast cancer

• Source: Cancer Cell International, Vol 24, Iss 1, Pp 1-15 (2024)

Record details

Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies

• Authors : Mohadeseh Haji Abdolvahab; Pegah Karimi; Nasrin Mohajeri

Subjects: VHH; Nanobody; Drug delivery

• Source: Cancer Cell International, Vol 24, Iss 1, Pp 1-18 (2024)

Record details

Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics

• Authors : Tatiana J. Carneiro; Ana L. M. Batista Carvalho; Martin Vojtek

Subjects: Triple negative breast cancer; MDA-MB-231 cell line; Cisplatin resistance

• Source: Cancer Cell International, Vol 23, Iss 1, Pp 1-17 (2023)

Record details

Optimization of tumor-treating field therapy for triple-negative breast cancer cells in vitro via frequency modulation

• Authors : Austin R. Smothers; Jason R. Henderson; John J. O’Connell

Subjects: Breast cancer; Electric field intensity; Frequency modulation

• Source: Cancer Cell International, Vol 23, Iss 1, Pp 1-8 (2023)

Record details